Published in TB and Outbreaks Week, July 23rd, 2002
In the absence of effective vaccination programs, meningococcal disease remains a major public health problem worldwide. In Europe, North America, and Australasia most cases occur in young children and adolescents and are caused by group B or C meningococcal bacteria. The U.K. was the first country to introduce vaccination against meningococcal group C disease in November 1999. The entire population age 18 years or younger - around 14 million people - were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.